Event Abstract Back to Event Identification and target of Th9 cell molecular signature Paula Licona-Limón1, 2*, Jorge Henao-Mejía2, 3 and Richard A. Flavell2, 4 1 UNAM, Biología Celular y del Desarrollo, Mexico 2 YALE UNIVERSITY, Immunobiology, United States 3 University of Pennsylvania, Pathology and Laboratory Medicine, United States 4 Howard Hughes Medical institute, United States Helminth infections and allergies are controlled by the prototypical cytokines IL-4, IL-5, IL-9 and IL-13, however the individual role of this cytokines as well as the cellular sources and the molecular mechanism controlling its expression in vivo are not completely understood. Among these cytokines, IL-9 has gain a lot of attention based on recent in vitro studies suggesting the existence of a T cell subpopulation expressing IL-9 named Th9. Our initial studies focused on determining the cellular sources of IL-9 and its targets in vivo by generating an IL-9 reporter (Interleukin Nine Fluorescent Reporter:INFER) as well as an IL-9 deficient mice. Using a hookworm infection model, we found that IL-9 is a central regulator of type 2 immunity in vivo by promoting IL-5 and IL-13 expression as well as basophilia and eosinophilia in mice infected with Nippostrongylus brasiliensis. We also demonstrated that IL-9 expression is induced in T cells and innate lymphoid cells (ILC2) early upon infection and that T cell derived IL-9 was sufficient to rescue the phenotype observed in IL-9 deficient mice. Furthermore our data also identify for the first time, functional differences between Th9 cells expressing IL-9 and bona fide classical Th2 cells (expressing IL-4). Based on our previous work, we are currently interested in defining the molecular signature of Th9 cells vs Th2 cells. We isolated effector Th2 and Th9 cells generated in vitro with naïve cells from the different reporter mice (INFER and 4get respectively) and compare the expression profile between them by RNA-seq. We identify two candidate molecules highly expressed in Th9 cells and target them for deletion with the CRISPR-Cas9 technology. We are currently analyzing the role of such molecules in Th9 differentiation and function both in vitro and in vivo. Our results will identify the molecular signals controlling Th9 biology and will certainly provide tools to control this important subpopulation in vivo. In the future we are also interested in defining the role of IL-9 in other pathologies such as autoimmune disease and cancer as well as the contribution and regulation of ILC2-derived IL-9 in vivo. Acknowledgements PEW Foundation References Licona-Limón P, Henao-Mejía J, Temann AU, Gagliani N, Licona-Limón I, Ishigame H, Hao L, De Broski H, Flavell RA. Th9 cells drive host immunity against gastrointestinal nematode infection. Immunity. 2013, Oct 17; 39(4):744-757. Keywords: IL-9, Th9 cell, Helminths, RNA sequencing, CRISPR/Cas9 Conference: IMMUNOCOLOMBIA2015 - 11th Congress of the Latin American Association of Immunology - 10o. Congreso de la Asociación Colombiana de Alergia, Asma e Inmunología, Medellin, Colombia, 13 Oct - 16 Oct, 2015. Presentation Type: Oral Presentation Topic: Infectious and parasitic diseases Citation: Licona-Limón P, Henao-Mejía J and Flavell RA (2015). Identification and target of Th9 cell molecular signature. Front. Immunol. Conference Abstract: IMMUNOCOLOMBIA2015 - 11th Congress of the Latin American Association of Immunology - 10o. Congreso de la Asociación Colombiana de Alergia, Asma e Inmunología. doi: 10.3389/conf.fimmu.2015.05.00333 Copyright: The abstracts in this collection have not been subject to any Frontiers peer review or checks, and are not endorsed by Frontiers. They are made available through the Frontiers publishing platform as a service to conference organizers and presenters. The copyright in the individual abstracts is owned by the author of each abstract or his/her employer unless otherwise stated. Each abstract, as well as the collection of abstracts, are published under a Creative Commons CC-BY 4.0 (attribution) licence (https://creativecommons.org/licenses/by/4.0/) and may thus be reproduced, translated, adapted and be the subject of derivative works provided the authors and Frontiers are attributed. For Frontiers’ terms and conditions please see https://www.frontiersin.org/legal/terms-and-conditions. Received: 09 May 2015; Published Online: 15 Sep 2015. * Correspondence: Dr. Paula Licona-Limón, UNAM, Biología Celular y del Desarrollo, Mexico, DF, 04510, Mexico, plicona@ifc.unam.mx Login Required This action requires you to be registered with Frontiers and logged in. To register or login click here. Abstract Info Abstract The Authors in Frontiers Paula Licona-Limón Jorge Henao-Mejía Richard A Flavell Google Paula Licona-Limón Jorge Henao-Mejía Richard A Flavell Google Scholar Paula Licona-Limón Jorge Henao-Mejía Richard A Flavell PubMed Paula Licona-Limón Jorge Henao-Mejía Richard A Flavell Related Article in Frontiers Google Scholar PubMed Abstract Close Back to top Javascript is disabled. Please enable Javascript in your browser settings in order to see all the content on this page.